AP-768
780763-95-3
|
ap-1-(9-fluorenyl)-2-(1-methylethenyl)naphthalene
134864-90-7
|
AP-III-a4
1177827-73-4
|
AP-1/NF-κB activation inhibitor 1
188936-12-1
|
AP-18
55224-94-7
|
AP C5
2234272-10-5
|
AP-III-a4 hydrochloride
2070014-95-6
|
AP 20187
195514-80-8
|
AP 1903
195514-63-7
|
3H-Pyrazolo[3,4-h]isoquinoline
480419-16-7
|
5-(2,4-Dichlorophenyl)-1,2,4-oxadiazol-3-amine
1432064-86-2
|
Methanone, (1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl-
1339750-00-3
|
5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-amine
1342422-95-0
|
(1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrazol-3-yl)boronic acid
256345-56-9
|
2-(1-Benzofuran-2-YL)-1H-1,3-benzodiazol-7-amine
1406700-21-7
|
4-Phenylspiro[chromene-2,4'-piperidine]hydrochloride
1394031-00-5
|
2-Fluoro-3-(trifluoromethoxy)aniline hydrochloride
1386459-74-0
|
2-chloro-N-(4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-4-(methylsulfonyl)benzamide
1552310-29-8
|
Spiro[piperidine-4,2'-pyrano[2,3-B]pyridin]-4'(3'H)-one hcl
2089650-31-5
|
